Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates.

Self-aggregates of low density lipoprotein (LDL) are taken up and degraded more rapidly by macrophages than is native LDL. That enhanced uptake is attributable in part to phagocytosis via the LDL receptor pathway. However, arterial macrophages appear to express little LDL receptor activity. The present studies demonstrate an alternative mechanism by which LDL aggregates could contribute to foam cell formation. This could occur by the formation of large immune complexes that are taken up by macrophages via the Fc receptor. When immune complexes were formed with native, soluble LDL and MB47, a monoclonal antibody specific to the apoprotein B domain recognized by the LDL receptor, the subsequent uptake and degradation of the LDL by macrophages were inhibited 50-80% compared with native LDL alone. In contrast, when aggregated LDL was bound to MB47 at a similar molar ratio, the subsequent degradation of the insoluble immune complexes was two- to fivefold greater than that of aggregated LDL alone. The enhanced uptake was abolished when Fab or F(ab')2 fragments of MB47 were substituted for the intact antibody, indicating that the increased uptake was via the Fc receptor pathway. Furthermore, the uptake of the immune complexes of aggregated LDL was reduced by competition for the Fc receptor with heat-aggregated immunoglobulin. There was also an increase in the rate of cellular cholesterol esterification and an increase in macrophage cholesteryl ester mass. Since aggregates of LDL as well as autoantibodies against modified LDL have been demonstrated in atherosclerotic lesions, it is possible that immune complexes of aggregates of modified LDL may be generated in the intima.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  J L Witztum,et al.  Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[2]  D. Steinberg,et al.  Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. , 1991, The Journal of clinical investigation.

[3]  G. Füst,et al.  Free and complexed anti-lipoprotein antibodies in vascular diseases. , 1983, Atherosclerosis.

[4]  M. Lopes-Virella,et al.  Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation , 1988, The Journal of experimental medicine.

[5]  S. Young,et al.  Conservation of the Low Density Lipoprotein Receptor‐Binding Domain of Apoprotein B , 1986, Arteriosclerosis.

[6]  A. G. Vinogradov,et al.  Lipoprotein-antibody immune complexes. Their catabolism and role in foam cell formation. , 1985, Atherosclerosis.

[7]  J. Salonen,et al.  Autoantibody against oxidised LDL and progression of carotid atherosclerosis , 1992, The Lancet.

[8]  A. Fogelman,et al.  Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein. A deep-etch and immunolocalization study of ultrarapidly frozen tissue. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[9]  A. Chait,et al.  Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam-cell formation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Falcone,et al.  Fibronectin Stimulates Macrophage Uptake of Low Density Lipoprotein‐Heparin‐Collagen Complexes , 1988, Arteriosclerosis.

[11]  D. Steinberg,et al.  Enhanced Macrophage Uptake of Low Density Lipoprotein after Self‐Aggregation , 1988, Arteriosclerosis.

[12]  M. Brown,et al.  Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. , 1983, Methods in enzymology.

[13]  K. Shunk,et al.  Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[14]  V. Tertov,et al.  Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins. , 1989, Biochemical and biophysical research communications.

[15]  S. Young,et al.  Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B. , 1986, Clinical chemistry.

[16]  Y. Aida,et al.  Triggering of the Superoxide Generation of Macrophages by Crosslinking of Fcγ Receptor , 1984 .

[17]  D. Brown,et al.  Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. , 1990, Archives of pathology & laboratory medicine.

[18]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[19]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[20]  N. Simionescu,et al.  Prelesional events in atherogenesis. Colocalization of apolipoprotein B, unesterified cholesterol and extracellular phospholipid liposomes in the aorta of hyperlipidemic rabbit. , 1987, Atherosclerosis.

[21]  V. Tertov,et al.  Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[22]  H F Hoff,et al.  Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[23]  M. Lopes-Virella,et al.  Erythrocyte-bound low-density lipoprotein immune complexes lead to cholesteryl ester accumulation in human monocyte-derived macrophages. , 1991, Clinical immunology and immunopathology.

[24]  O. Quehenberger,et al.  Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages. , 1989, Arteriosclerosis.

[25]  A. Fogelman,et al.  Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching. , 1989, Journal of lipid research.

[26]  J. Sykes,et al.  Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen). , 1981, Analytical biochemistry.

[27]  J. Avigan,et al.  Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells. , 1978, Journal of lipid research.

[28]  S. Ylä-Herttuala,et al.  Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. , 1990, Arteriosclerosis.

[29]  S. Srinivasan,et al.  Complexes of low-density lipoproteins and arterial proteoglycan aggregates promote cholesteryl ester accumulation in mouse macrophages. , 1985, Biochimica et biophysica acta.

[30]  D. Morel,et al.  Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin. , 1989, Journal of immunology.

[31]  G. Camejo,et al.  Effect of arterial proteoglycans on the interaction of LDL with human monocyte-derived macrophages. , 1987, Atherosclerosis.

[32]  J. Witztum,et al.  Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for derivatized lysine. , 1984, Journal of lipid research.

[33]  C. Nathan,et al.  Hydrogen peroxide release from mouse peritoneal macrophages: dependence on sequential activation and triggering , 1977, The Journal of experimental medicine.

[34]  A. Chait,et al.  Superoxide initiates oxidation of low density lipoprotein by human monocytes. , 1987, Arteriosclerosis.

[35]  J L Witztum,et al.  Low density lipoprotein undergoes oxidative modification in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. Silverstein,et al.  Studies on the mechanism of phagocytosis. I. Requirements for circumferential attachment of particle-bound ligands to specific receptors on the macrophage plasma membrane , 1975, The Journal of experimental medicine.

[37]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[38]  J L Witztum,et al.  Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.